Overview
Genomic analysis for metastatic breast cancer(MBC) patients
- Participant (Inclusion criteria)
- Patients who diagnosed metastatic/stage IV breast cancer
- Patients who were not received treatment for metastatic breast cancer on palliative setting
- Process
(1) Tissue/ Blood sample
- At diagnosis, MBC tissue / blood sample (20cc) will be obtained.
- At disease progression after 1st line treatment for MBC, blood sample (20cc) will be obtained (tissue; optional)
(2) WES, RNASeq, ctDNA, Exosome
- We will analyze genomic characteritics using WES, RNASeq, ctDNA, Exosome.
Eligibility
Inclusion Criteria:
- Patients who diagnosed ad metastatic breast cancer
- Patients who were not received treatment on palliative setting
Exclusion Criteria:
- Patients who did not agree this study
- Patients who did not have any pathologic specimen at MBC diagnosis.